Success Stories - i2i – innovations to innovation

6 Start-ups

and M&As made successful: co-founding, leading, exiting, global licensing ….

$ 14 Million

equity financing secured at various biotech start-ups.

$ 16 Million

revenue growth. From USD 8 mil to $ 24 mil in 2 years at a large company.

Selected Case Studies

Licensing / Partnership

License Platform Bio-chemicals Technology from a NASDAQ listed biotech company to a large chemical company

A USD 10 bil. US based NASDAQ listed biotech company needed to evaluate the potential for a new fermentation technology to manufacture bio-based platform molecules. They engaged i2i who investigated the capability and potential of the technology, evaluated the organization’s capabilities to commercialize the technology, researched and identified potential licensing partners and assisted in executing its commercial partnership.

Market Penetration

Extending the use of biopolymers via additive technology

A global polymer / chemical company wanted to investigate new markets for an additive and employed i2i. i2i tested the additive in various biopolymers at an independent test laboratory and found substantial improvement in several properties in biopolymers. i2i then investigated the market potential based on these property improvements and recommended the next steps in commercializing the additive in the biopolymers.

Start-up spinout

Spin out a bio based nutraceutical from a University Incubator

A European university / research incubator wanted to develop biotechnological processes for new bio based molecules using their biotechnology tool box, when they called i2i to investigate potential target molecules. i2i investigated and identified several target molecules to the incubator. The incubator developed the processes for two of the molecules. i2i is currently engaged in spinning out a start-up based on the two molecules that the incubator has developed.

Ready to write your success story?

Making a difference,
Leaving impressions

Endorsements

“His sharp analytical mind combined with solid commercial skills makes him a good consultant in both the Materials Sciences and Life Sciences space.”

— ROB KIRSCHBAUM

FORMER BUSINESS GROUP DIRECTOR, DSM

“Anindya helped us bring prospective customers and clients for commercialization of the technology and its product to the table.”

— JOHAN VAN WALSEM

CURRENT COO, LYGOS, BERKELEY, CA | FORMER COO, METABOLIX, CAMBRIDGE, MA

“Anindya is a proactive entrepreneur with an impressive background both in life sciences as materials. Over the years, he has built a large international network. He is a good communicator, delivers on his commitments and is customer focused.”

— VOLKERT CLAASSEN

FORMER PRESIDENT OF INDUSTRIAL BIOTECHNOLOGY, DSM

“Anindya has a high quality network across the industry. He’s made very valuable contributions to Metabolix’s commercialization efforts.”

— MAX SENECHAL

FORMER VP STRATEGY AND COMMERCIAL DEVELOPMENT, METABOLIX, CAMBRIDGE, MA | CURRENTLY DIRECTOR, ARTHER D. LITTLE CONSULTING

“Anindya helped us identify and research target products and with market research. Anindya wrote business plans, prepared licensing/financing presentations, did financial planning/models, and using his network helped us develop production models for the new products.”